Status:
UNKNOWN
Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant
Lead Sponsor:
Methodist Health System
Conditions:
Polyomavirus Infections
BK Viremia
Eligibility:
All Genders
18-100 years
Brief Summary
The human BK polyomavirus is a significant risk factor for renal transplant dysfunction and allograft loss. The prevalence of BK viremia (BKV) following kidney transplantation is estimated to be 10-20...
Detailed Description
The human BK polyomavirus is a significant risk factor for renal transplant dysfunction and allograft loss. The prevalence of BK viremia (BKV) following kidney transplantation is estimated to be 10-20...
Eligibility Criteria
Inclusion
- Age 18 years or older
- SLK recipients transplanted at MDMC between 2015-2020
Exclusion
- Below 18 years of age
- Patients who did not undergo SLK transplant at MDMC
Key Trial Info
Start Date :
November 17 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 17 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05224583
Start Date
November 17 2021
End Date
November 17 2022
Last Update
March 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Methodist Dallas Medical Center
Dallas, Texas, United States, 75203